The Degen Study: Post-market Clinical Follow-up on the PASS LP, PASS Degen and PASS Tulip Systems (PASS DEGEN)

计划入组 77 人 · 首次发布于 2020 年 12 月 17 日

Clinical Utility Study for Exo-PDAC

首次发布于 2023 年 1 月 27 日

Avacostar - (PASS)

计划入组 507 人 · 首次发布于 2023 年 6 月 9 日

EXO-226

EXO-050

Exo-1

Exo Biologics

Belgium

N&N Pharmaceuticals, Inc.

United States

n-Lorem Foundation

United States

LISCure Biosciences Secures First-Ever Regulatory Approval for Hair Health Probiotic Ingredient

Feasibility Pilot Trial on First-Pass Intubation Success Rates

Advancing Personalized Medicine: The Rise of N-of-1 Therapies for Rare Diseases